In this episode of the CanadianSME Small Business Podcast, we delve into the remarkable journey of Mick Lautt, CEO and co-founder of SciMar Ltd. Mick discusses the genesis of SciMar, a bio-research company on the cusp of a scientific breakthrough poised to transform the treatment of type 2 diabetes globally. From its early days to securing over $19 million in investment and navigating the biotech industry's challenges, Mick shares insights into the role of hepatalin in diabetes management, SciMar's path through research and development, and the innovative funding strategies propelling the company forward.
Key Highlight Points:
We express our deepest appreciation to Mick Lautt for sharing the inspiring story of SciMar Ltd with us. Mick's narrative underscores the importance of scientific innovation, strategic entrepreneurship, and community engagement in addressing global health challenges. His advice for aspiring entrepreneurs at the intersection of science and business highlights the need for resilience, innovation, and a focus on making a tangible difference.
Special thanks to our partners – RBC, UPS, Xero, and Constant Contact – for their support, enabling us to spotlight transformative stories like SciMar's.
For listeners seeking inspiration and practical insights, subscribe to CanadianSME Small Business Magazine at www.canadiansme.ca. Stay tuned for more episodes that illuminate the path for SMEs striving to make an impact in their industries and beyond.